Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice
The DOI matches its Crossref record.
Abstract
Summary: Activated platelets, which release platelet factor 4 (PF4) are present in patients with atherosclerosis. To date, no direct invivo evidence exists for the involvement of PF4 in atherogenesis. In the current study, we tested the hypothesis that PF4 is atherogenic, and that genetic elimination of PF4 would protect mice from atherosclerosis. We have bred PF4-/- mice onto two athero-susceptible backgrounds, WT-C57Bl/6(WT) and apoE-/- to examine the importance of PF4 in atherogenesis. In order to induce atherosclerosis, WT and PF4-/- mice were fed an atherogenic diet for 30 weeks, while apoE-/- and apoE-/- PF4-/- mice were fed a high-fat Western-style diet for 10 weeks. Examination of lesions in the aortic roots of atherogenic diet fed mice demonstrated reduced atherosclerosis in PF4-/- (20% compared to WT). Examination of apoE-/- mice demonstrated similar changes, with apoE-/- PF4-/- mice demonstrating 37% of the aortic atherosclerotic burden compared to apoE-/- mice. Although we found similar levels of total and non-HDL cholesterol inWT and PF4-/- mice, HDL-cholesterol levels were increased in PF4-/- on both backgrounds. These data demonstrate, for the first time, that the platelet specific chemokine PF4 promotes atherosclerotic lesion development in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Atherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Platelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
Cochain, C., Vafadarnejad, E., Arampatzi, P., Pelisek, J., Winkels, H., Ley, K., Wolf, D., Saliba, A.-E., & Zernecke, A. (2018) · Circulation Research · doi:10.1161/circresaha.117.312509 · Cited by 894
Emerging roles for platelets as immune and inflammatory cells
Morrell, C. N., Aggrey, A. A., Chapman, L. M., & Modjeski, K. L. (2014) · Blood · doi:10.1182/blood-2013-11-462432 · Cited by 735
The Hemostatic System as a Modulator of Atherosclerosis
Borissoff, J. I., Spronk, H. M. H., & ten Cate, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011670 · Cited by 569
Monocyte and Macrophage Dynamics During Atherogenesis
Ley, K., Miller, Y. I., & Hedrick, C. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.221127 · Cited by 554
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Ramji, D. P., & Davies, T. S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.04.003 · Cited by 469
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Heme oxygenase–1, oxidation, inflammation, and atherosclerosis
Araujo, J. A., Zhang, M., & Yin, F. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00119 · Cited by 443
“M4 macrophages appear to play a proatherogenic role, which is consistent with the ∼60% decrease in aortic atherosclerotic lesions exhibited by CXCL-4−/−ApoE−/−mice (Sachais et al., 2007).”
ResultKoenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Chemokines in Atherosclerosis: An Update
Zernecke, A., Shagdarsuren, E., & Weber, C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.161174 · Cited by 376
Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis
Sluimer, J. C., & Daemen, M. J. (2009) · The Journal of Pathology · doi:10.1002/path.2518 · Cited by 367
Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis
Gleissner, C. A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00001 · Cited by 339
Hoeft, K., Schaefer, G. J. L., Kim, H., Schumacher, D., Bleckwehl, T., Long, Q., Klinkhammer, B. M., Peisker, F., Koch, L., Nagai, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112131 · Cited by 326
Platelet Chemokines in Vascular Disease
Gleissner, C. A., von Hundelshausen, P., & Ley, K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.169417 · Cited by 314
CXCR3 ligands in disease and therapy
Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J., & Struyf, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 310
CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
Gleissner, C. A., Shaked, I., Little, K. M., & Ley, K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901368 · Cited by 286
Platelet-derived chemokines in inflammation and atherosclerosis
Bakogiannis, C., Sachse, M., Stamatelopoulos, K., & Stellos, K. (2019) · Cytokine · doi:10.1016/j.cyto.2017.09.013 · Cited by 281
Platelet Interaction with Innate Immune Cells
Kral, J. B., Schrottmaier, W. C., Salzmann, M., & Assinger, A. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000444807 · Cited by 255
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073868 · Cited by 253
Update on lipids, inflammation and atherothrombosis
Storey, R., Vilahur, G., & Badimon, L. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0717 · Cited by 180
Inflammatory Chemokines in Atherosclerosis
Gencer, S., Evans, B. R., van der Vorst, E. P. C., Döring, Y., & Weber, C. (2021) · Cells · doi:10.3390/cells10020226 · Cited by 177
“Although M4 macrophages share characteristics of both M1 and M2 they still possess an overall pro-atherogenic effect, as the deletion of the PF4 gene encoding for CXCL4 results in reduced lesion size in atherosclerotic ApoE−/− mice [33].”
BackgroundVandercappellen, J., Van Damme, J., & Struyf, S. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.011 · Cited by 173
“els Lipoprotein analysis [151]”
BackgroundInfluentialPlatelet Factor 4 Mediates Inflammation in Experimental Cerebral Malaria
Srivastava, K., Cockburn, I. A., Swaim, A., Thompson, L. E., Tripathi, A., Fletcher, C. A., Shirk, E. M., Sun, H., Kowalska, M. A., Fox-Talbot, K., et al. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.003 · Cited by 168
“PF4 / mice have been well characterized (Eslin et al., 2004; Sachais et al., 2007) and have normal complete blood counts and platelet activation (Table S1 and Figure S3).”
BackgroundCXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages
Gleissner, C. A., Shaked, I., Erbel, C., Böckler, D., Katus, H. A., & Ley, K. (2010) · Circulation Research · doi:10.1161/circresaha.109.199505 · Cited by 165
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice
Drescher, H. K., Brandt, E. F., Fischer, P., Dreschers, S., Schwendener, R. A., Kowalska, M. A., Canbay, A., Wasmuth, H. E., Weiskirchen, R., Trautwein, C., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00326 · Cited by 17
“PF4−/− animals with a target deletion of the PF4 gene were established on the C57BL/6 background as described (Sachais et al., 2007) and backcrossed for more than 10 generations.”
Method
Metadata
- Authors
- Turrentine, T., Dawicki McKenna, J., Rux, A., Rader, D., Kowalska, A., & Sachais, B.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007
- Volume
- 98
- Issue
- 11
- Pages
- 1108-1113
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2049094974
- Cited by
- 147
- References
- 0
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.